JPWO2020203086A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020203086A5 JPWO2020203086A5 JP2021511318A JP2021511318A JPWO2020203086A5 JP WO2020203086 A5 JPWO2020203086 A5 JP WO2020203086A5 JP 2021511318 A JP2021511318 A JP 2021511318A JP 2021511318 A JP2021511318 A JP 2021511318A JP WO2020203086 A5 JPWO2020203086 A5 JP WO2020203086A5
- Authority
- JP
- Japan
- Prior art keywords
- blood glucose
- osmotic pressure
- suppressing
- increase
- peritoneal dialysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 46
- 239000008103 glucose Substances 0.000 claims 33
- 239000008280 blood Substances 0.000 claims 25
- 210000004369 blood Anatomy 0.000 claims 25
- 230000003204 osmotic effect Effects 0.000 claims 22
- 238000000034 method Methods 0.000 claims 14
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 11
- 239000000385 dialysis solution Substances 0.000 claims 10
- 238000000502 dialysis Methods 0.000 claims 9
- 239000003978 infusion fluid Substances 0.000 claims 9
- 238000010521 absorption reaction Methods 0.000 claims 8
- 238000001802 infusion Methods 0.000 claims 8
- 208000035473 Communicable disease Diseases 0.000 claims 5
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- 239000003792 electrolyte Substances 0.000 claims 3
- 210000004303 peritoneum Anatomy 0.000 claims 3
- 230000033228 biological regulation Effects 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- 210000001015 abdomen Anatomy 0.000 claims 1
- 210000000683 abdominal cavity Anatomy 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000008151 electrolyte solution Substances 0.000 claims 1
- 210000003722 extracellular fluid Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019065393 | 2019-03-29 | ||
| PCT/JP2020/010232 WO2020203086A1 (ja) | 2019-03-29 | 2020-03-10 | Ｄ－アロースおよび／またはｄ－アルロースを含有してなる腹膜透析液の浸透圧調整剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2020203086A1 JPWO2020203086A1 (https=) | 2020-10-08 |
| JPWO2020203086A5 true JPWO2020203086A5 (https=) | 2022-03-11 |
Family
ID=72668623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511318A Pending JPWO2020203086A1 (https=) | 2019-03-29 | 2020-03-10 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220175931A1 (https=) |
| EP (1) | EP3950057A4 (https=) |
| JP (1) | JPWO2020203086A1 (https=) |
| CN (1) | CN113710317A (https=) |
| BR (1) | BR112021016283A2 (https=) |
| CA (1) | CA3134085A1 (https=) |
| WO (1) | WO2020203086A1 (https=) |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4943839B1 (https=) | 1968-06-10 | 1974-11-25 | ||
| JPS5330976B1 (https=) | 1971-07-22 | 1978-08-30 | ||
| JPS5317055B2 (https=) | 1972-08-09 | 1978-06-06 | ||
| US3991349A (en) | 1975-01-03 | 1976-11-09 | Westinghouse Electric Corporation | Droop adjustable control apparatus for direct current motor drives |
| JPS5316164A (en) | 1976-07-27 | 1978-02-14 | Aisin Seiki Co Ltd | Fluid coupling device |
| JPS589701B2 (ja) | 1977-06-04 | 1983-02-22 | 株式会社栗本鉄工所 | 廃棄物処理装置 |
| JPH1171273A (ja) | 1997-08-29 | 1999-03-16 | Terumo Corp | 腹膜透析液 |
| JP4473980B2 (ja) | 1999-06-24 | 2010-06-02 | 株式会社林原生物化学研究所 | 糖質複合体結晶とその製造方法 |
| JP4499882B2 (ja) | 2000-07-07 | 2010-07-07 | 株式会社林原生物化学研究所 | Ｄ−キシロース・イソメラーゼを用いるアルドヘキソースの製造方法 |
| JP4882054B2 (ja) | 2000-09-13 | 2012-02-22 | 独立行政法人科学技術振興機構 | 腹膜透析液およびその調製法 |
| CN1668735A (zh) * | 2002-05-22 | 2005-09-14 | 国立大学法人香川大学 | 稀有糖的生物活性的利用方法及配合了稀有糖的组合物 |
| JP2005102503A (ja) | 2003-01-10 | 2005-04-21 | Kagawa Univ | 新しい触媒機能を有するｌ−ラムノースイソメラーゼの遺伝子配列およびその用途 |
| JP5421512B2 (ja) * | 2004-01-30 | 2014-02-19 | 帝國製薬株式会社 | Ｄ−プシコースの血糖上昇抑制効果の利用 |
| JP4724824B2 (ja) | 2004-03-19 | 2011-07-13 | 国立大学法人 香川大学 | 希少糖のｔリンパ球の増殖抑制への使用 |
| JP4888937B2 (ja) * | 2004-05-24 | 2012-02-29 | 国立大学法人 香川大学 | 微生物増殖抑制への希少糖の使用 |
| US7691619B2 (en) | 2004-08-24 | 2010-04-06 | Rare Sugar Production Technical Research Laboratories, Llc | Sequence of thermotolerant L-rhamnose isomerase gene and use of the same |
| EP1864669B1 (en) | 2005-03-23 | 2018-06-27 | Rare Sugar Production Technical Research Laboratories, LLC | Application of d-psicose to suppression of abnormal circadian increase in blood glucose level |
| KR100744479B1 (ko) | 2005-06-01 | 2007-08-01 | 씨제이 주식회사 | 사이코스 에피머화 효소에 의한 사이코스의 생산 방법 |
| JP5116072B2 (ja) * | 2005-07-20 | 2013-01-09 | 帝國製薬株式会社 | Ｄ−アロースの血糖上昇抑制効果の利用 |
| US8440619B2 (en) | 2005-08-31 | 2013-05-14 | National University Corporation Kagawa University | Utilization of hypertension/hypercardia-preventing effect of D-allose |
| JP2009269887A (ja) | 2008-05-09 | 2009-11-19 | Kagawa Univ | 希少糖を含有する腹膜劣化抑制剤、腹膜透析液および腹膜透析法 |
| WO2012011588A1 (ja) * | 2010-07-23 | 2012-01-26 | 学校法人東海大学 | 腹膜透析患者用の経口医薬組成物及びその用法 |
| AR086745A1 (es) * | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
| JP5997693B2 (ja) | 2011-07-06 | 2016-09-28 | 松谷化学工業株式会社 | アルスロバクターグロビホルミスの生産する酵素 |
-
2020
- 2020-03-10 BR BR112021016283-6A patent/BR112021016283A2/pt unknown
- 2020-03-10 CA CA3134085A patent/CA3134085A1/en active Pending
- 2020-03-10 JP JP2021511318A patent/JPWO2020203086A1/ja active Pending
- 2020-03-10 US US17/599,252 patent/US20220175931A1/en active Pending
- 2020-03-10 WO PCT/JP2020/010232 patent/WO2020203086A1/ja not_active Ceased
- 2020-03-10 EP EP20781293.4A patent/EP3950057A4/en active Pending
- 2020-03-10 CN CN202080024937.6A patent/CN113710317A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7053059B2 (en) | Dialysis solutions with reduced levels of glucose degradation products | |
| US4879280A (en) | Dialysis solution for use in intraperitoneal dialysis | |
| EP1753437B1 (en) | Bicarbonate-based peritoneal dialysis solutions | |
| Bullock et al. | The use of hypertonic sucrose solution intravenously to reduce cerebrospinal fluid pressure without a secondary rise | |
| JP4638106B2 (ja) | 医薬的使用のための溶液中における浸透圧剤としての、ｌ−カルニチンおよびそのアルカノイル誘導体の使用 | |
| JP2015515480A (ja) | エチレンオキシド滅菌下のｐＨ安定性が改善された注入液 | |
| EP1682205A1 (en) | Implantable infusion pump for the administration of intrathecal gabapentin for treatment of pain | |
| JP7520166B2 (ja) | 腹膜透析液、腹膜透析液セット、腹膜透析に使用される組成物および腹膜透析を行う方法 | |
| US8445029B2 (en) | Plasma-adapted full electrolyte solution | |
| CN118976116B (zh) | 琥珀酰明胶在制备腹膜透析液中的用途以及一种含琥珀酰明胶、枸橼酸钠的腹膜透析液 | |
| JPWO2020203086A5 (https=) | ||
| JP2008120798A (ja) | ヘパリン製剤 | |
| Abbott et al. | Sodium nitroprusside in idiopathic respiratory distress syndrome | |
| CN102240261A (zh) | 一种葡甘露聚糖注射液的制备方法及其医学用途 | |
| JP3643879B2 (ja) | 電解質輸液組成物 | |
| CN104379134A (zh) | 肠外艾司洛尔剂型 | |
| CN107753505A (zh) | 一种复方电解质注射液 | |
| JP4802492B2 (ja) | ヘパリン含有プレフィルドシリンジ製剤 | |
| RU2431488C1 (ru) | Фармацевтическая композиция на основе гидроксиэтилкрахмала в гипертоническом растворе натрия хлорида для использования в качестве плазмозаменяющего раствора в случаях малообъемной реанимации | |
| Rodeck et al. | Successful treatment of fetal cardiac arrest by left ventricular exchange transfusion | |
| RU2271836C1 (ru) | Способ обеспечения глубокой гиперволемической гемодилюции | |
| Wang et al. | Effect of nicardipine combined with esmolol on systemic and tissue oxygenation during off-pump coronary artery bypass grafting surgery | |
| RU2582219C2 (ru) | Плазмозамещающий раствор | |
| Riley et al. | Intravenous Fluids | |
| CN114533759A (zh) | 一种钠钾镁钙葡萄糖注射液组合物及其制备方法 |